Global Biosimilars Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilars Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biosimilars by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biosimilars by Country/Region, 2017, 2022 & 2028

2.2 Biosimilars Segment by Type

2.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)

2.2.2 Recombinant Glycosylated Proteins

2.3 Biosimilars Sales by Type

2.3.1 Global Biosimilars Sales Market Share by Type (2017-2022)

2.3.2 Global Biosimilars Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biosimilars Sale Price by Type (2017-2022)

2.4 Biosimilars Segment by Application

2.4.1 Oncology

2.4.2 Blood Disorders

2.4.3 Growth Hormonal Deficiency

2.4.4 Chronic and Autoimmune Disorders

2.4.5 Others

2.5 Biosimilars Sales by Application

2.5.1 Global Biosimilars Sale Market Share by Application (2017-2022)

2.5.2 Global Biosimilars Revenue and Market Share by Application (2017-2022)

2.5.3 Global Biosimilars Sale Price by Application (2017-2022)

3 Global Biosimilars by Company

3.1 Global Biosimilars Breakdown Data by Company

3.1.1 Global Biosimilars Annual Sales by Company (2020-2022)

3.1.2 Global Biosimilars Sales Market Share by Company (2020-2022)

3.2 Global Biosimilars Annual Revenue by Company (2020-2022)

3.2.1 Global Biosimilars Revenue by Company (2020-2022)

3.2.2 Global Biosimilars Revenue Market Share by Company (2020-2022)

3.3 Global Biosimilars Sale Price by Company

3.4 Key Manufacturers Biosimilars Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilars Product Location Distribution

3.4.2 Players Biosimilars Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biosimilars by Geographic Region

4.1 World Historic Biosimilars Market Size by Geographic Region (2017-2022)

4.1.1 Global Biosimilars Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biosimilars Annual Revenue by Geographic Region

4.2 World Historic Biosimilars Market Size by Country/Region (2017-2022)

4.2.1 Global Biosimilars Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biosimilars Annual Revenue by Country/Region

4.3 Americas Biosimilars Sales Growth

4.4 APAC Biosimilars Sales Growth

4.5 Europe Biosimilars Sales Growth

4.6 Middle East & Africa Biosimilars Sales Growth

5 Americas

5.1 Americas Biosimilars Sales by Country

5.1.1 Americas Biosimilars Sales by Country (2017-2022)

5.1.2 Americas Biosimilars Revenue by Country (2017-2022)

5.2 Americas Biosimilars Sales by Type

5.3 Americas Biosimilars Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilars Sales by Region

6.1.1 APAC Biosimilars Sales by Region (2017-2022)

6.1.2 APAC Biosimilars Revenue by Region (2017-2022)

6.2 APAC Biosimilars Sales by Type

6.3 APAC Biosimilars Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biosimilars by Country

7.1.1 Europe Biosimilars Sales by Country (2017-2022)

7.1.2 Europe Biosimilars Revenue by Country (2017-2022)

7.2 Europe Biosimilars Sales by Type

7.3 Europe Biosimilars Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilars by Country

8.1.1 Middle East & Africa Biosimilars Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biosimilars Revenue by Country (2017-2022)

8.2 Middle East & Africa Biosimilars Sales by Type

8.3 Middle East & Africa Biosimilars Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biosimilars

10.3 Manufacturing Process Analysis of Biosimilars

10.4 Industry Chain Structure of Biosimilars

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biosimilars Distributors

11.3 Biosimilars Customer

12 World Forecast Review for Biosimilars by Geographic Region

12.1 Global Biosimilars Market Size Forecast by Region

12.1.1 Global Biosimilars Forecast by Region (2023-2028)

12.1.2 Global Biosimilars Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biosimilars Forecast by Type

12.7 Global Biosimilars Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Biosimilars Product Offered

13.1.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis Biosimilars Product Offered

13.2.3 Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Biocon

13.3.1 Biocon Company Information

13.3.2 Biocon Biosimilars Product Offered

13.3.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biocon Main Business Overview

13.3.5 Biocon Latest Developments

13.4 Biogen

13.4.1 Biogen Company Information

13.4.2 Biogen Biosimilars Product Offered

13.4.3 Biogen Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biogen Main Business Overview

13.4.5 Biogen Latest Developments

13.5 Fresenius Kabi AG

13.5.1 Fresenius Kabi AG Company Information

13.5.2 Fresenius Kabi AG Biosimilars Product Offered

13.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Fresenius Kabi AG Main Business Overview

13.5.5 Fresenius Kabi AG Latest Developments

13.6 Boehringer Ingelheim

13.6.1 Boehringer Ingelheim Company Information

13.6.2 Boehringer Ingelheim Biosimilars Product Offered

13.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Boehringer Ingelheim Main Business Overview

13.6.5 Boehringer Ingelheim Latest Developments

13.7 Merck KgaA

13.7.1 Merck KgaA Company Information

13.7.2 Merck KgaA Biosimilars Product Offered

13.7.3 Merck KgaA Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck KgaA Main Business Overview

13.7.5 Merck KgaA Latest Developments

13.8 Mylan

13.8.1 Mylan Company Information

13.8.2 Mylan Biosimilars Product Offered

13.8.3 Mylan Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mylan Main Business Overview

13.8.5 Mylan Latest Developments

13.9 Eli Lilly

13.9.1 Eli Lilly Company Information

13.9.2 Eli Lilly Biosimilars Product Offered

13.9.3 Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly Main Business Overview

13.9.5 Eli Lilly Latest Developments

13.10 Teva Pharmaceutical

13.10.1 Teva Pharmaceutical Company Information

13.10.2 Teva Pharmaceutical Biosimilars Product Offered

13.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceutical Main Business Overview

13.10.5 Teva Pharmaceutical Latest Developments

13.11 Dr. Reddy's Laboratories

13.11.1 Dr. Reddy's Laboratories Company Information

13.11.2 Dr. Reddy's Laboratories Biosimilars Product Offered

13.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Dr. Reddy's Laboratories Main Business Overview

13.11.5 Dr. Reddy's Laboratories Latest Developments

13.12 Amgen

13.12.1 Amgen Company Information

13.12.2 Amgen Biosimilars Product Offered

13.12.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Amgen Main Business Overview

13.12.5 Amgen Latest Developments

13.13 Celltrion

13.13.1 Celltrion Company Information

13.13.2 Celltrion Biosimilars Product Offered

13.13.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Celltrion Main Business Overview

13.13.5 Celltrion Latest Developments

13.14 Samsung Biologics

13.14.1 Samsung Biologics Company Information

13.14.2 Samsung Biologics Biosimilars Product Offered

13.14.3 Samsung Biologics Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Samsung Biologics Main Business Overview

13.14.5 Samsung Biologics Latest Developments

13.15 Roche

13.15.1 Roche Company Information

13.15.2 Roche Biosimilars Product Offered

13.15.3 Roche Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Roche Main Business Overview

13.15.5 Roche Latest Developments

13.16 Probiomed

13.16.1 Probiomed Company Information

13.16.2 Probiomed Biosimilars Product Offered

13.16.3 Probiomed Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Probiomed Main Business Overview

13.16.5 Probiomed Latest Developments

13.17 Apotex

13.17.1 Apotex Company Information

13.17.2 Apotex Biosimilars Product Offered

13.17.3 Apotex Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Apotex Main Business Overview

13.17.5 Apotex Latest Developments

13.18 Chong Kun Dang

13.18.1 Chong Kun Dang Company Information

13.18.2 Chong Kun Dang Biosimilars Product Offered

13.18.3 Chong Kun Dang Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Chong Kun Dang Main Business Overview

13.18.5 Chong Kun Dang Latest Developments

13.19 JCR Pharmaceuticals

13.19.1 JCR Pharmaceuticals Company Information

13.19.2 JCR Pharmaceuticals Biosimilars Product Offered

13.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 JCR Pharmaceuticals Main Business Overview

13.19.5 JCR Pharmaceuticals Latest Developments

13.20 Gan & Lee Pharmaceuticals

13.20.1 Gan & Lee Pharmaceuticals Company Information

13.20.2 Gan & Lee Pharmaceuticals Biosimilars Product Offered

13.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Gan & Lee Pharmaceuticals Main Business Overview

13.20.5 Gan & Lee Pharmaceuticals Latest Developments

13.21 Gedeon Richter

13.21.1 Gedeon Richter Company Information

13.21.2 Gedeon Richter Biosimilars Product Offered

13.21.3 Gedeon Richter Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Gedeon Richter Main Business Overview

13.21.5 Gedeon Richter Latest Developments

13.22 Biocad

13.22.1 Biocad Company Information

13.22.2 Biocad Biosimilars Product Offered

13.22.3 Biocad Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Biocad Main Business Overview

13.22.5 Biocad Latest Developments

13.23 Coherus Bioscience

13.23.1 Coherus Bioscience Company Information

13.23.2 Coherus Bioscience Biosimilars Product Offered

13.23.3 Coherus Bioscience Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Coherus Bioscience Main Business Overview

13.23.5 Coherus Bioscience Latest Developments

13.24 Stada Arzneimittel AG

13.24.1 Stada Arzneimittel AG Company Information

13.24.2 Stada Arzneimittel AG Biosimilars Product Offered

13.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Stada Arzneimittel AG Main Business Overview

13.24.5 Stada Arzneimittel AG Latest Developments

14 Research Findings and Conclusion

Table 1. Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)

Table 4. Major Players of Recombinant Glycosylated Proteins

Table 5. Global Biosimilars Sales by Type (2017-2022) & (K MT)

Table 6. Global Biosimilars Sales Market Share by Type (2017-2022)

Table 7. Global Biosimilars Revenue by Type (2017-2022) & ($ million)

Table 8. Global Biosimilars Revenue Market Share by Type (2017-2022)

Table 9. Global Biosimilars Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Biosimilars Sales by Application (2017-2022) & (K MT)

Table 11. Global Biosimilars Sales Market Share by Application (2017-2022)

Table 12. Global Biosimilars Revenue by Application (2017-2022)

Table 13. Global Biosimilars Revenue Market Share by Application (2017-2022)

Table 14. Global Biosimilars Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Biosimilars Sales by Company (2020-2022) & (K MT)

Table 16. Global Biosimilars Sales Market Share by Company (2020-2022)

Table 17. Global Biosimilars Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Biosimilars Revenue Market Share by Company (2020-2022)

Table 19. Global Biosimilars Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Biosimilars Producing Area Distribution and Sales Area

Table 21. Players Biosimilars Products Offered

Table 22. Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Biosimilars Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Biosimilars Sales Market Share Geographic Region (2017-2022)

Table 27. Global Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Biosimilars Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Biosimilars Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Biosimilars Sales Market Share by Country/Region (2017-2022)

Table 31. Global Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Biosimilars Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Biosimilars Sales by Country (2017-2022) & (K MT)

Table 34. Americas Biosimilars Sales Market Share by Country (2017-2022)

Table 35. Americas Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Biosimilars Revenue Market Share by Country (2017-2022)

Table 37. Americas Biosimilars Sales by Type (2017-2022) & (K MT)

Table 38. Americas Biosimilars Sales Market Share by Type (2017-2022)

Table 39. Americas Biosimilars Sales by Application (2017-2022) & (K MT)

Table 40. Americas Biosimilars Sales Market Share by Application (2017-2022)

Table 41. APAC Biosimilars Sales by Region (2017-2022) & (K MT)

Table 42. APAC Biosimilars Sales Market Share by Region (2017-2022)

Table 43. APAC Biosimilars Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Biosimilars Revenue Market Share by Region (2017-2022)

Table 45. APAC Biosimilars Sales by Type (2017-2022) & (K MT)

Table 46. APAC Biosimilars Sales Market Share by Type (2017-2022)

Table 47. APAC Biosimilars Sales by Application (2017-2022) & (K MT)

Table 48. APAC Biosimilars Sales Market Share by Application (2017-2022)

Table 49. Europe Biosimilars Sales by Country (2017-2022) & (K MT)

Table 50. Europe Biosimilars Sales Market Share by Country (2017-2022)

Table 51. Europe Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Biosimilars Revenue Market Share by Country (2017-2022)

Table 53. Europe Biosimilars Sales by Type (2017-2022) & (K MT)

Table 54. Europe Biosimilars Sales Market Share by Type (2017-2022)

Table 55. Europe Biosimilars Sales by Application (2017-2022) & (K MT)

Table 56. Europe Biosimilars Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Biosimilars Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Biosimilars Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Biosimilars Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Biosimilars Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Biosimilars Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Biosimilars Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Biosimilars Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Biosimilars

Table 66. Key Market Challenges & Risks of Biosimilars

Table 67. Key Industry Trends of Biosimilars

Table 68. Biosimilars Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Biosimilars Distributors List

Table 71. Biosimilars Customer List

Table 72. Global Biosimilars Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Biosimilars Sales Market Forecast by Region

Table 74. Global Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Biosimilars Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Biosimilars Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Biosimilars Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Biosimilars Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Biosimilars Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Biosimilars Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Biosimilars Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Biosimilars Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Biosimilars Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Biosimilars Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Biosimilars Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer Biosimilars Product Offered

Table 94. Pfizer Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. Novartis Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 98. Novartis Biosimilars Product Offered

Table 99. Novartis Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Novartis Main Business

Table 101. Novartis Latest Developments

Table 102. Biocon Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 103. Biocon Biosimilars Product Offered

Table 104. Biocon Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Biocon Main Business

Table 106. Biocon Latest Developments

Table 107. Biogen Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 108. Biogen Biosimilars Product Offered

Table 109. Biogen Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Biogen Main Business

Table 111. Biogen Latest Developments

Table 112. Fresenius Kabi AG Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 113. Fresenius Kabi AG Biosimilars Product Offered

Table 114. Fresenius Kabi AG Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Fresenius Kabi AG Main Business

Table 116. Fresenius Kabi AG Latest Developments

Table 117. Boehringer Ingelheim Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 118. Boehringer Ingelheim Biosimilars Product Offered

Table 119. Boehringer Ingelheim Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Boehringer Ingelheim Main Business

Table 121. Boehringer Ingelheim Latest Developments

Table 122. Merck KgaA Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 123. Merck KgaA Biosimilars Product Offered

Table 124. Merck KgaA Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Merck KgaA Main Business

Table 126. Merck KgaA Latest Developments

Table 127. Mylan Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 128. Mylan Biosimilars Product Offered

Table 129. Mylan Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Mylan Main Business

Table 131. Mylan Latest Developments

Table 132. Eli Lilly Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 133. Eli Lilly Biosimilars Product Offered

Table 134. Eli Lilly Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Eli Lilly Main Business

Table 136. Eli Lilly Latest Developments

Table 137. Teva Pharmaceutical Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 138. Teva Pharmaceutical Biosimilars Product Offered

Table 139. Teva Pharmaceutical Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. Teva Pharmaceutical Main Business

Table 141. Teva Pharmaceutical Latest Developments

Table 142. Dr. Reddy's Laboratories Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 143. Dr. Reddy's Laboratories Biosimilars Product Offered

Table 144. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. Dr. Reddy's Laboratories Main Business

Table 146. Dr. Reddy's Laboratories Latest Developments

Table 147. Amgen Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 148. Amgen Biosimilars Product Offered

Table 149. Amgen Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 150. Amgen Main Business

Table 151. Amgen Latest Developments

Table 152. Celltrion Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 153. Celltrion Biosimilars Product Offered

Table 154. Celltrion Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 155. Celltrion Main Business

Table 156. Celltrion Latest Developments

Table 157. Samsung Biologics Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 158. Samsung Biologics Biosimilars Product Offered

Table 159. Samsung Biologics Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 160. Samsung Biologics Main Business

Table 161. Samsung Biologics Latest Developments

Table 162. Roche Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 163. Roche Biosimilars Product Offered

Table 164. Roche Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 165. Roche Main Business

Table 166. Roche Latest Developments

Table 167. Probiomed Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 168. Probiomed Biosimilars Product Offered

Table 169. Probiomed Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 170. Probiomed Main Business

Table 171. Probiomed Latest Developments

Table 172. Apotex Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 173. Apotex Biosimilars Product Offered

Table 174. Apotex Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 175. Apotex Main Business

Table 176. Apotex Latest Developments

Table 177. Chong Kun Dang Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 178. Chong Kun Dang Biosimilars Product Offered

Table 179. Chong Kun Dang Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 180. Chong Kun Dang Main Business

Table 181. Chong Kun Dang Latest Developments

Table 182. JCR Pharmaceuticals Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 183. JCR Pharmaceuticals Biosimilars Product Offered

Table 184. JCR Pharmaceuticals Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 185. JCR Pharmaceuticals Main Business

Table 186. JCR Pharmaceuticals Latest Developments

Table 187. Gan & Lee Pharmaceuticals Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 188. Gan & Lee Pharmaceuticals Biosimilars Product Offered

Table 189. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 190. Gan & Lee Pharmaceuticals Main Business

Table 191. Gan & Lee Pharmaceuticals Latest Developments

Table 192. Gedeon Richter Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 193. Gedeon Richter Biosimilars Product Offered

Table 194. Gedeon Richter Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 195. Gedeon Richter Main Business

Table 196. Gedeon Richter Latest Developments

Table 197. Biocad Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 198. Biocad Biosimilars Product Offered

Table 199. Biocad Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 200. Biocad Main Business

Table 201. Biocad Latest Developments

Table 202. Coherus Bioscience Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 203. Coherus Bioscience Biosimilars Product Offered

Table 204. Coherus Bioscience Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 205. Coherus Bioscience Main Business

Table 206. Coherus Bioscience Latest Developments

Table 207. Stada Arzneimittel AG Basic Information, Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 208. Stada Arzneimittel AG Biosimilars Product Offered

Table 209. Stada Arzneimittel AG Biosimilars Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 210. Stada Arzneimittel AG Main Business

Table 211. Stada Arzneimittel AG Latest Developments

List of Figures

Figure 1. Picture of Biosimilars

Figure 2. Biosimilars Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilars Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biosimilars Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)

Figure 10. Product Picture of Recombinant Glycosylated Proteins

Figure 11. Global Biosimilars Sales Market Share by Type in 2021

Figure 12. Global Biosimilars Revenue Market Share by Type (2017-2022)

Figure 13. Biosimilars Consumed in Oncology

Figure 14. Global Biosimilars Market: Oncology (2017-2022) & (K MT)

Figure 15. Biosimilars Consumed in Blood Disorders

Figure 16. Global Biosimilars Market: Blood Disorders (2017-2022) & (K MT)

Figure 17. Biosimilars Consumed in Growth Hormonal Deficiency

Figure 18. Global Biosimilars Market: Growth Hormonal Deficiency (2017-2022) & (K MT)

Figure 19. Biosimilars Consumed in Chronic and Autoimmune Disorders

Figure 20. Global Biosimilars Market: Chronic and Autoimmune Disorders (2017-2022) & (K MT)

Figure 21. Biosimilars Consumed in Others

Figure 22. Global Biosimilars Market: Others (2017-2022) & (K MT)

Figure 23. Global Biosimilars Sales Market Share by Application (2017-2022)

Figure 24. Global Biosimilars Revenue Market Share by Application in 2021

Figure 25. Biosimilars Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Biosimilars Revenue Market Share by Company in 2021

Figure 27. Global Biosimilars Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Biosimilars Revenue Market Share by Geographic Region in 2021

Figure 29. Global Biosimilars Sales Market Share by Region (2017-2022)

Figure 30. Global Biosimilars Revenue Market Share by Country/Region in 2021

Figure 31. Americas Biosimilars Sales 2017-2022 (K MT)

Figure 32. Americas Biosimilars Revenue 2017-2022 ($ Millions)

Figure 33. APAC Biosimilars Sales 2017-2022 (K MT)

Figure 34. APAC Biosimilars Revenue 2017-2022 ($ Millions)

Figure 35. Europe Biosimilars Sales 2017-2022 (K MT)

Figure 36. Europe Biosimilars Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Biosimilars Sales 2017-2022 (K MT)

Figure 38. Middle East & Africa Biosimilars Revenue 2017-2022 ($ Millions)

Figure 39. Americas Biosimilars Sales Market Share by Country in 2021

Figure 40. Americas Biosimilars Revenue Market Share by Country in 2021

Figure 41. United States Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Biosimilars Sales Market Share by Region in 2021

Figure 46. APAC Biosimilars Revenue Market Share by Regions in 2021

Figure 47. China Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Biosimilars Sales Market Share by Country in 2021

Figure 54. Europe Biosimilars Revenue Market Share by Country in 2021

Figure 55. Germany Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Biosimilars Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Biosimilars Revenue Market Share by Country in 2021

Figure 62. Egypt Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Biosimilars in 2021

Figure 68. Manufacturing Process Analysis of Biosimilars

Figure 69. Industry Chain Structure of Biosimilars

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles